Clinical trial · Interventional
Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters
Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheter-Related Bloodstream Infections in Pediatric Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections". These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chlorhexidine Dressing | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control
- description
- Standard care bundle approach; The following materials will be used by nurses while performing their care in accordance with the relevant care bundle and checklist; * Transparent catheter cover (3M™ IV-Tegaderm™) (Control group) * Needle-free interventional apparatus (BD Qsyte split septum™), * Prefilled flush syringe (BD PosiFlush™) * Alcohol swab (alcohol cloth), * Solupred Swab (3M™), (will be used to clean the dressing area)
- type
- EXPERIMENTAL
- label
- Care bundle approach with Chlorhexidine Dressing
- description
- Care bundle approach with Chlorhexidine Dressing The following materials will be used by nurses while performing their care in accordance with the relevant care bundle and checklist; * Transparent catheter cover with Chlorhexidine (3M™ CHG Tegaderm™) (Study group) * Needle-free interventional apparatus (BD Qsyte split septum™), * Prefilled flush syringe (BD PosiFlush™) * Alcohol swab (alcohol cloth), * Solupred Swab (3M™), (will be used to clean the dressing area)
- interventionNames
- Device: Chlorhexidine Dressing
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit * The child has a diagnosis of hematological or oncological cancer * The child's age range is between 1 and 17 * Having a port catheter inserted and no early complications have occurred * The child agrees to participate in the study voluntarily * The parent agrees to participate in the study voluntarily * Obtaining the consent form from the child and parent * He has been in the hospital for more than 48 hours Exclusion Criteria: * Have a systemic infection.
References
Publications (0)
Data not yet available